Japanese Encephalitis Medication

1. Howard-Jones AR, Pham D, Jeoffreys N, Eden J-S, Hueston L, Kesson AM, et al. Emerging Genotype IV Japanese Encephalitis Virus Outbreak in New South Wales, Australia. Viruses. 2022 Aug 24. 14(9):1853. [Full Text].

2. Lobigs M, Diamond M. Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex. Expert Rev Vaccines. 2012 Feb. 11(2):177-87. [QxMD MEDLINE Link]. [Full Text].

3. Solomon T, Ni H, Beasley DW, Ekkelenkamp M, Cardosa MJ, Barrett AD. Origin and Evolution of Japanese Encephalitis Virus in Southeast Asia. J Virol. 2003 Mar. 77(5):3091-8. [QxMD MEDLINE Link]. [Full Text].

4. Pham D, Howard-Jones A, Hueston L, Jeoffreys N, Doggett S, Rockett R, et al. Emergence of Japanese encephalitis in Australia: a diagnostic perspective. Pathology. 2022 Aug 19. 54 (6):669-677. [Full Text].

5. Takhampunya R, Kim HC, Tippayachai B, Kengluecha A, Klein TA, Lee WJ, et al. Emergence of Japanese encephalitis virus genotype V in the Republic of Korea. Virol J. 2011 Sep 23. 8:449:[QxMD MEDLINE Link]. [Full Text].

6. Unni SK, Ružek D, Chhatbar C, Mishra R, Johri MK, Singh SK. Japanese encephalitis virus: from genome to infectome. Microbes Infect. 2011 Apr. 13(4):312-21. [QxMD MEDLINE Link].

7. Turtle, L., Solomon, T. Japanese encephalitis — the prospects for new treatments. Nature Reviews Neuology. 2018. 14:298-313. [Full Text].

8. Thongtan T, Cheepsunthorn P, Chaiworakul V, Rattanarungsan C, Wikan N, Smith DR. Highly permissive infection of microglial cells by Japanese encephalitis virus: a possible role as a viral reservoir. Microbes Infect. 2010 Jan. 12(1):37-45. [QxMD MEDLINE Link].

9. Shukla V, Shakya AK, Shukla M, Kumari N, Krishnani N, Dhole TN, et al. Circulating levels of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases during Japanese encephalitis virus infection. Virusdisease. 2016 Mar. 27(1):63-76. [QxMD MEDLINE Link].

10. Hills SL, Stoltey J, Martinez D, Kim P, Sheriff H, Zangeneh A, et al. Journal of Travel Medicine. 2014 Sep-Oct. 21(5):310-313. [Full Text].

11. Hills SL, Griggs AC, Fischer M. Japanese encephalitis in travelers from non-endemic countries, 1973-2008. Am J Trop Med Hyg. 2010 May. 82(5):930-6. [QxMD MEDLINE Link]. [Full Text].

12. Hills, S.L., Lindsey, N.P., Fischer, M. Japanese Encephalitis. CDC Yellow Book. Available at https://wwwnc.cdc.gov/travel/yellowbook/2020/travel-related-infectious-diseases/japanese-encephalitis. 2019 Jun 24; Accessed: March 9,2023.

13. Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, Hombach JM, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ. 2011 Oct 1. 89(10):766-74E. [QxMD MEDLINE Link]. [Full Text].

14. Hanna JN, Ritchie SA, Phillips DA, Shield J, Bailey MC, Mackenzie JS, et al. An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust. 1996 Sep 2. 165(5):256-60. [QxMD MEDLINE Link].

15. Baylis M, Barker CM, Caminade C, Joshi BR, Pant GR, Rayamajhi A, et al. Emergence or improved detection of Japanese encephalitis virus in the Himalayan highlands?. Trans R Soc Trop Med Hyg. 2016 Apr. 110(4):209-11. [QxMD MEDLINE Link]. [Full Text].

16. Kumar R, Tripathi P, Singh S, Bannerji G. Clinical features in children hospitalized during the 2005 epidemic of Japanese encephalitis in Uttar Pradesh, India. Clin Infect Dis. 2006 Jul 15. 43(2):123-31. [QxMD MEDLINE Link].

17. Li X, Cui S, Gao X, Wang H, Song M, Li M, et al. The Spatio-temporal Distribution of Japanese Encephalitis Cases in Different Age Groups in Mainland China, 2004 - 2014. PLoS Negl Trop Dis. 2016 Apr 6. 10(4):[QxMD MEDLINE Link]. [Full Text].

18. Australian Government. Japanese Encephalitis Virus. Available at https://www.health.gov.au/health-alerts/japanese-encephalitis-virus-jev/japanese-encephalitis-virus-jev. 2023 Feb 28; Accessed: March 9, 2023.

19. WHO. Japanese Encephalitis Vaccines: WHO position paper, February 2015 - Recommendations. Vaccine. 2016 Jan 12. 34(3):302-3. [QxMD MEDLINE Link].

20. Sarkari NB, Thacker AK, Barthwal SP, Mishra VK, Prapann S, Srivastava D, et al. Japanese encephalitis (JE) part II: 14 years' follow-up of survivors. J Neurol. 2012 Jan. 259 (1):58-69. [QxMD MEDLINE Link].

21. Richman DD, Whitley RJ, Hayden FG. Clinical Virology. New York, NY: Churchill Livingstone; 1997.

22. Bandyopadhyay D, Ganesan V, Choudhury C, Kar SS, Karmakar P, Choudhary V, et al. Two Uncommon Causes of Guillain-Barré Syndrome: Hepatitis E and Japanese Encephalitis. Case Rep Neurol Med. 2015. 2015:[QxMD MEDLINE Link]. [Full Text].

23. Handique SK, Das RR, Saharia B, Das P, Buragohain R, Saikia P. Coinfection of Japanese encephalitis with neurocysticercosis: an imaging study. AJNR Am J Neuroradiol. 2008 Jan. 29(1):170-5. [QxMD MEDLINE Link]. [Full Text].

24. CDC. Japanese Encephalitis in Two Children — United States, 2010. MMWR Morb Mortal Wkly Rep. 2011 Mar 11. 60(9):276-8. [QxMD MEDLINE Link]. [Full Text].

25. Suman V, Roy U, Panwar A, Raizada A. Japanese Encephalitis Complicated with Obstructive Hydrocephalus. J Clin Diagn Res. 2016 Feb. 10(20):OD18-20. [QxMD MEDLINE Link]. [Full Text].

26. Chen WL, Liao MF, Chiang HL, Lin SK. A possible case of acute disseminated encephalomyelitis after Japanese encephalitis. Acta Neurol Taiwan. 2013 Dec. 22(4):169-73. [QxMD MEDLINE Link]. [Full Text].

27. Verma R, Praharaj HN, Patil TB, Giri P. Acute transverse myelitis following Japanese encephalitis viral infection: an uncommon complication of a common disease. BMJ Case Rep. 2012 Sep 24. 2012:[QxMD MEDLINE Link].

28. Chanama, S., et al. Detection of Japanese encephalitis (JE) virus-specific IgM in cerebrospinal fluid and serum samples from JE patients. Jpn J Infect Dis. 2005 Oct 01. 58(5):294. [Full Text].

29. Solomon T, Thao LT, Dung NM, Kneen R, Hung NT, Nisalak A, et al. Rapid diagnosis of Japanese encephalitis by using an immunoglobulin M dot enzyme immunoassay. J Clin Microbiol. 1998 Jul. 36(7):2030-4. [QxMD MEDLINE Link]. [Full Text].

30. Hoke CH Jr, Vaughn DW, Nisalak A, Intralawan P, Poolsuppasit S, Jongsawas V, et al. Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus. J Infect Dis. 1992 Apr. 165(4):631-7. [QxMD MEDLINE Link].

31. Harinasuta C, Nimmanitya S, Titsyakorn U. The effect of interferon-alpha A on two cases of Japanese encephalitis in Thailand. Southeast Asian J Trop Med Public Health. 1985 Jun. 16(2):332-6. [QxMD MEDLINE Link].

32. Solomon T, Dung NM, Wills B, Kneen R, Gainsborough M, Diet TV, et al. Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet. 2003 Mar 8. 361(9360):821-6. [QxMD MEDLINE Link].

33. Rayamajhi A, Nightingale S, Bhatta NK, Singh R, Kneen R, Ledger E, et al. A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal. PLoS One. 2015 Apr 17. 10(4):[QxMD MEDLINE Link]. [Full Text].

34. Lee E, Pavy M, Young N, Freeman C, Lobigs M. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses. Antiviral Res. 2006 Jan. 69(1):31-8. [QxMD MEDLINE Link].

35. Saxena SK, Mathur A, Srivastava RC. Inhibition of Japanese encephalitis virus infection by diethyldithiocarbamate is independent of its antioxidant potential. Antivir Chem Chemother. 2003 Mar. 14(2):91-8. [QxMD MEDLINE Link].

36. Swarup V, Ghosh J, Mishra MK, Basu A. Novel strategy for treatment of Japanese encephalitis using arctigenin, a plant lignan. J Antimicrob Chemother. 2008 Mar. 61(3):679-88. [QxMD MEDLINE Link].

37. Dutta K, Basu A. Use of minocycline in viral infections. Indian J Med Res. 2011 May. 133:467-70. [QxMD MEDLINE Link]. [Full Text].

38. Mishra MK, Basu A. Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis. J Neurochem. 2008 Jun. 105(5):1582-95. [QxMD MEDLINE Link]. [Full Text].

39. Kumar R, Basu A, Sinha S, Das M, Tripathi P, Jain A, et al. Role of oral Minocycline in acute encephalitis syndrome in India - a randomized controlled trial. BMC Infect Dis. 2016 Feb 4. 16(1):67. [QxMD MEDLINE Link]. [Full Text].

40. Topno R, Khan SA, Chowdhury P, Mahanta J. Pharmacodynamics of aminoglycosides and tetracycline derivatives against Japanese encephalitis virus. Asian Pac J Trop Med. 2016 Mar. 9(3):241-6. [QxMD MEDLINE Link]. [Full Text].

41. Ixiaro (Japanese encephalitis vaccine, inactivated, adsorbed) [package insert]. Gaithersburg, MD: Valneva USA, Inc. April, 2018. Available at [Full Text].

42. [Guideline] Hills SL, Walter EB, Atmar RL, Fischer M. Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2019 Jul 19. 58(2):1-33. [Full Text].

43. Harakuni T, Kohama H, Tadano M, et al. Mucosal vaccination approach against mosquito-borne Japanese encephalitis virus. Jpn J Infect Dis. 2009 Jan. 62(1):37-45. [QxMD MEDLINE Link].

44. Yang DK, Kweon CH, Kim BH, Hwang IJ, Kang MI, So BJ, et al. The seroprevalence of Japanese encephalitis virus in goats raised in Korea. J Vet Sci. 2007 Jun. 8(2):197-9. [QxMD MEDLINE Link]. [Full Text].

45. Schiøler KL, Samuel M, Wai KL. Vaccines for preventing Japanese encephalitis. Cochrane Database Syst Rev. 2007 Jul 18. CD004263. [QxMD MEDLINE Link].

46. Yang SE, Pan MJ, Tseng HF, Liau MY. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan. Vaccine. 2006 Mar 24. 24(14):2669-73. [QxMD MEDLINE Link].

47. Connor BA, Bunn WB. The Changing Risk of Japanese Encephalitis for Business Travelers. Workplace Health Saf. 2015 Dec. 63 (12):568. [QxMD MEDLINE Link].

48. Ravi V, Taly AB, Shankar SK, Shenoy PK, Desai A, Nagaraja D, et al. Association of Japanese encephalitis virus infection with Guillain-Barré syndrome in endemic areas of south India. Acta Neurol Scand. 1994 Jul. 90(1):67-72. [QxMD MEDLINE Link].

49. Kuwayama M, Ito M, Takao S, Shimazu Y, Fukuda S, Miyazaki K, et al. Japanese encephalitis virus in meningitis patients, Japan. Emerg Infect Dis. 2005 Mar. 11(3):471-3. [QxMD MEDLINE Link].

50. Chokephaibulkit K, Houillon G, Feroldi E, Bouckenooghe A. Safety and immunogenicity of live attenuated Japanese encephalitis chimeric virus vaccine (Imojev^®) in children. Expert Rev Vaccines. 2015 Nov 20. [QxMD MEDLINE Link].

51. Solomon T, Thao TT, Lewthwaite P, Ooi MH, Kneen R, Dung NM, et al. A cohort study to assess the new WHO Japanese encephalitis surveillance standards. Bull World Health Organ. 2008 Mar. 86(3):178-86. [QxMD MEDLINE Link]. [Full Text].

52. Dwibedi B, Mohapatra N, Rathore SK, Panda M, Pati SS, Sabat J, et al. An outbreak of Japanese encephalitis after two decades in Odisha, India. Indian J Med Res. 2015 Dec. 142 Suppl:S30-2. [QxMD MEDLINE Link]. [Full Text].

53. Centers for Disease Control and Prevention. CDC Health Information For International Travel 2016. New York: Oxford University Press; 2016.

54. Burke DS, Nisalak A, Ussery MA, Laorakpongse T, Chantavibul S. Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis. 1985 Jun. 151(6):1093-9. [QxMD MEDLINE Link].

Antonette B Climaco, MD Attending Physician, Division of Infectious Diseases, Department of Medicine, Einstein Healthcare Network

Antonette B Climaco, MD is a member of the following medical societies: American Academy of HIV Medicine, HIV Medicine Association, Infectious Diseases Society of America, Philippine Medical Association

Disclosure: Nothing to disclose.

Raymond Smith, MBBS Resident Physician, Department of Internal Medicine, Albert Einstein Medical Center

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Michael Stuart Bronze, MD David Ross Boyd Professor and Chairman, Department of Medicine, Stewart G Wolf Endowed Chair in Internal Medicine, Department of Medicine, University of Oklahoma Health Science Center; Master of the American College of Physicians; Fellow, Infectious Diseases Society of America; Fellow of the Royal College of Physicians, London

Michael Stuart Bronze, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American Medical Association, Association of Professors of Medicine, Infectious Diseases Society of America, Oklahoma State Medical Association, Southern Society for Clinical Investigation

Disclosure: Nothing to disclose.

Asim A Jani, MD, MPH, FACP Clinician-Educator and Epidemiologist, Consultant and Senior Physician, Florida Department of Health; Diplomate, Infectious Diseases, Internal Medicine and Preventive Medicine

Asim A Jani, MD, MPH, FACP is a member of the following medical societies: American Association of Public Health Physicians, American College of Physicians, American College of Preventive Medicine, American Medical Association, American Public Health Association, Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Katherine Talcott Melhado, DO Resident Physician, Department of Internal Medicine, Einstein Medical Center

Disclosure: Nothing to disclose.

Joseph F John Jr, MD, FACP, FIDSA, FSHEA Clinical Professor of Medicine, Molecular Genetics and Microbiology, Medical University of South Carolina College of Medicine; Associate Chief of Staff for Education, Ralph H Johnson Veterans Affairs Medical Center

Disclosure: Nothing to disclose.

Alexander J Kallen, MD Instructor of Medicine, Department of Internal Medicine, Division of Outcomes Research, Dartmouth Medical School, Veterans Affairs Medical Center of White River Junction, VT

Alexander J Kallen, MD is a member of the following medical societies: American College of Physicians, American Medical Association, American Society for Microbiology, California Medical Association, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Klaus-Dieter Lessnau, MD, FCCP Clinical Associate Professor of Medicine, New York University School of Medicine; Medical Director, Pulmonary Physiology Laboratory; Director of Research in Pulmonary Medicine, Department of Medicine, Section of Pulmonary Medicine, Lenox Hill Hospital

Klaus-Dieter Lessnau, MD, FCCP is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Medical Association, American Thoracic Society, and Society of Critical Care Medicine

Disclosure: Sepracor None None

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

What would you like to print?

• Print this section
• Print the entire contents of
• Print the entire contents of article